Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Controlled Trial ◽

Small Cell ◽

Small Cell Lung ◽

Previously Treated ◽

Faculty Opinions recommendation of Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726044364.793539633 ◽

2017 ◽

Cited By ~ 2

Author(s):

Patrick Nana-Sinkam

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Controlled Trial ◽

Small Cell ◽

Small Cell Lung ◽

Previously Treated ◽

MEDIASTinal staging of non-small cell lung cancer by endobronchial and endoscopic ultrasonography with or without additional surgical mediastinoscopy (MEDIASTrial): study protocol of a multicenter randomised controlled trial

BMC Surgery ◽

10.1186/s12893-018-0359-6 ◽

2018 ◽

Vol 18 (1) ◽

Cited By ~ 12

Author(s):

Jelle E. Bousema ◽

◽

Marcel G. W. Dijkgraaf ◽

Nicole E. Papen-Botterhuis ◽

Hermien W. Schreurs ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Endoscopic Ultrasonography ◽

Study Protocol ◽

Cell Lung Cancer ◽

Controlled Trial ◽

Small Cell ◽

Small Cell Lung ◽

Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial

The Lancet ◽

10.1016/s0140-6736(16)32517-x ◽

2017 ◽

Vol 389 (10066) ◽

pp. 255-265 ◽

Cited By ~ 1731

Author(s):

Achim Rittmeyer ◽

Fabrice Barlesi ◽

Daniel Waterkamp ◽

Keunchil Park ◽

Fortunato Ciardiello ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Controlled Trial ◽

Small Cell ◽

Small Cell Lung ◽

Open Label ◽

Phase 3 ◽

Previously Treated ◽

Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial

The Lancet Oncology ◽

10.1016/s1470-2045(06)70804-x ◽

2006 ◽

Vol 7 (9) ◽

pp. 719-727 ◽

Cited By ~ 934

Author(s):

Jean-Yves Douillard ◽

Rafael Rosell ◽

Mario De Lena ◽

Francesco Carpagnano ◽

Rodryg Ramlau ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Controlled Trial ◽

Small Cell ◽

Small Cell Lung ◽

Stage Ib ◽

Resected Stage ◽

Early palliative care based on warm model in patients with non-small-cell lung cancer: a randomised controlled trial

Clinical Nutrition ESPEN ◽

10.1016/j.clnesp.2021.09.079 ◽

2021 ◽

Vol 46 ◽

pp. S568

Author(s):

M. Chen ◽

H. Yu ◽

L. Yang ◽

S. Wang ◽

L. Tian ◽

...

Keyword(s):

Lung Cancer ◽

Palliative Care ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Controlled Trial ◽

Small Cell ◽

Small Cell Lung ◽

Early Palliative Care ◽

S35 A randomised controlled trial comparing combined EBUS/EUS followed by surgical staging versus surgical staging alone in non-small cell lung cancer: the ASTER study

Thorax ◽

10.1136/thx.2010.150912.35 ◽

2010 ◽

Vol 65 (Suppl 4) ◽

pp. A18-A18

Author(s):

R. C. Rintoul ◽

K. G. Tournoy ◽

C. Dooms ◽

P. De Leyn ◽

A. G. Nicholson ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Controlled Trial ◽

Small Cell ◽

Surgical Staging ◽

Small Cell Lung ◽

Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial

Yearbook of Pulmonary Disease ◽

10.1016/s8756-3452(08)70619-4 ◽

2008 ◽

Vol 2008 ◽

pp. 150-151

Author(s):

L.T. Tanoue

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Controlled Trial ◽

Small Cell ◽

Small Cell Lung ◽

Stage Ib ◽

Resected Stage ◽

A phase III randomised controlled trial of erlotinib vs gefitinib in advanced non-small cell lung cancer with EGFR mutations

British Journal of Cancer ◽

10.1038/bjc.2016.456 ◽

2017 ◽

Vol 116 (5) ◽

pp. 568-574 ◽

Cited By ~ 79

Author(s):

J J Yang ◽

Q Zhou ◽

H H Yan ◽

X C Zhang ◽

H J Chen ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Controlled Trial ◽

Small Cell ◽

Phase Iii ◽

Egfr Mutations ◽

Small Cell Lung ◽

A multicentre randomised controlled trial of nutritional intervention for patients with weight loss who are undergoing chemotherapy for gastrointestinal (GI) Malignancy, Non Small Cell Lung cancer (NSCL) or Mesothelioma

http://isrctn.org/> ◽

10.1186/isrctn86266498 ◽

2012 ◽

Author(s):

Jervoise Andreyev

Keyword(s):

Lung Cancer ◽

Weight Loss ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Controlled Trial ◽

Nutritional Intervention ◽

Small Cell ◽

Small Cell Lung ◽

A randomised controlled trial of pre-operative chemotherapy followed, if feasible, by resection versus radiotherapy in patients with inoperable stage T3, N1, M0 or T1-3, N2, M0 non-small cell lung cancer

Lung Cancer ◽

10.1016/j.lungcan.2005.04.001 ◽

2005 ◽

Vol 49 (3) ◽

pp. 395-400 ◽

Cited By ~ 25

Author(s):

Richard J. Stephens ◽

David J. Girling ◽

Penelope Hopwood ◽

Nicholas Thatcher

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Controlled Trial ◽

Small Cell ◽

Small Cell Lung ◽